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Role of Dorsomedial Striatum Neuronal Ensembles in
Incubation of Methamphetamine Craving after Voluntary
Abstinence
XDaniele Caprioli,* XMarco Venniro,* Michelle Zhang, X Jennifer M. Bossert, Brandon L. Warren, XBruce T. Hope,
and XYavin Shaham
Behavioral Neuroscience Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore,
Maryland 21224
We recently developed a rat model of incubation of methamphetamine craving after choice-based voluntary abstinence. Here, we
studied the role of dorsolateral striatum (DLS) and dorsomedial striatum (DMS) in this incubation. We trained rats to self-
administer palatable food pellets (6 d, 6 h/d) and methamphetamine (12 d, 6 h/d). We then assessed relapse to methamphetamine
seeking under extinction conditions after 1 and 21 abstinence days. Between tests, the rats underwent voluntary abstinence (using
a discrete choice procedure betweenmethamphetamine and food; 20 trials/d) for 19 d.We used in situ hybridization tomeasure the
colabeling of the activity marker Fos with Drd1 and Drd2 in DMS and DLS after the tests. Based on the in situ hybridization
colabeling results, we tested the causal role of DMS D1 and D2 family receptors, and DMS neuronal ensembles in “incubated”
methamphetamine seeking, using selective dopamine receptor antagonists (SCH39166 or raclopride) and the Daun02 chemoge-
netic inactivation procedure, respectively. Methamphetamine seeking was higher after 21 d of voluntary abstinence than after 1 d
(incubation of methamphetamine craving). The incubated response was associated with increased Fos expression in DMS but not
in DLS; Fos was colabeled with both Drd1 and Drd2. DMS injections of SCH39166 or raclopride selectively decreased methamphet-
amine seeking after 21 abstinence days. In Fos-lacZ transgenic rats, selective inactivation of relapse test-activated Fos neurons in
DMS on abstinence day 18 decreased incubatedmethamphetamine seeking on day 21. Results demonstrate a role of DMS dopamine
D1 and D2 receptors in the incubation of methamphetamine craving after voluntary abstinence and that DMS neuronal ensembles
mediate this incubation.
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Introduction
A fundamental feature of addiction to methamphetamine (Raw-
son et al., 2004) and other abused drugs (Hunt et al., 1971; Jaffe,
1990) is the high rate of relapse during abstinence. In rats, drug
seeking progressively increases after forced abstinence from co-
caine (Tran-Nguyen et al., 1998; Grimm et al., 2001), heroin
(Shalev et al., 2001), nicotine (Abdolahi et al., 2010), alcohol
(Bienkowski et al., 2004), and methamphetamine (Li et al.,
2015a) self-administration, a phenomenon termed “incubation
of drug craving” (Lu et al., 2004). These studies inspired clinical
studies demonstrating the incubation of nicotine (Bedi et al.,
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Significance Statement
In human addicts, abstinence is often self-imposed and relapse can be triggered by exposure to drug-associated cues that induce
drug craving. We recently developed a rat model of incubation of methamphetamine craving after choice-based voluntary absti-
nence. Here, we used classical pharmacology, in situ hybridization, immunohistochemistry, and the Daun02 inactivation proce-
dure to demonstrate a critical role of dorsomedial striatum neuronal ensembles in this new form of incubation of drug craving.
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2011), alcohol (Li et al., 2015b), cocaine (Parvaz et al., 2016), and
methamphetamine (Wang et al., 2013) craving in humans.
Despite the translational utility of the established rat ‘incuba-
tion of drug craving’ model, from a human relapse perspective,
the model’s limitation is that the abstinence period is
experimenter-imposed or forced (Venniro et al., 2016). In hu-
mans, abstinence is often voluntary due to either the adverse
consequences of drug use or the presence of alternative rewards
(Marlatt, 1996; Epstein and Preston, 2003). Based on these con-
siderations, we recently developed a choice-based rat model of
relapse after voluntary abstinence (Caprioli et al., 2015b). In this
model, which is based on the seminal studies of Lenoir et al.
(2007) and Ahmed et al. (2013), rats with a history of palatable
food and methamphetamine self-administration voluntarily
abstain from drug self-administration when given a mutually
exclusive choice between the two rewards (Caprioli et al.,
2015b). In our first study (Caprioli et al., 2015b), we used the
model to demonstrate that time-dependent increases in meth-
amphetamine seeking (incubation of methamphetamine crav-
ing) reliably occur after voluntary abstinence when the
alternative nondrug reward is discontinued.
Here, we began to characterize themechanisms of incubation of
methamphetamine craving after voluntary abstinence by determin-
ing the roleofdorsolateral striatum(DLS)anddorsomedial striatum
(DMS). Studies using animalmodels of relapse/reinstatement dem-
onstrated a role of these two striatal subregions in relapse to heroin
(Bossert et al., 2009), cocaine (Fuchs et al., 2006; Pacchioni et al.,
2011), alcohol (Wanget al., 2010), andmethamphetamine (Rubioet
al., 2015) seeking.Additionally,we recently found that incubationof
methamphetamine craving after forced abstinence is associatedwith
increasedexpressionof theactivitymarkerFos (MorganandCurran,
1991) in both DLS andDMS, and that blockade of D1 family recep-
tors in these subregions decrease “incubated”drug seeking after 30d
of forced abstinence (Li et al., 2015c).
We first used RNAscope in situ hybridization (ISH; Wang et
al., 2012) to determine whether the time-dependent increase in
methamphetamine seeking (incubation of methamphetamine
craving) after voluntary abstinence is associated with time-
dependent increases in Fos in dopamine D1 and D2 receptor-
expressing cells (Drd1 and Drd2) in DMS and DLS. We found
that incubated methamphetamine seeking was associated with
increased Fos in DMS but not in DLS, and that Fos was colabeled
with bothDrd1 andDrd2. Based on these results, we determined
the effect of DMS injections of the D1 and D2 family receptor
antagonists SCH39166 (Chipkin et al., 1988) and raclopride
(Ko¨hler et al., 1985) on incubated methamphetamine seeking.
We next determined a role of activated Fos-expressing neu-
rons in DMS in incubated methamphetamine seeking using the
Daun02 inactivation procedure that was developed to determine
causal roles of neuronal ensembles in learned behaviors (Koya et
al., 2009). In this procedure, selective inhibition of behaviorally
relevant activated neuronal ensembles is performed by injecting
the prodrug Daun02 into specific brain areas of Fos-lacZ trans-
genic rats (Kasof et al., 1996) that express -galactosidase (-gal;
the lacZ gene protein product) in neurons strongly activated
during behavior (Cruz et al., 2013). Daun02 is cleaved into
daunorubicin by -gal expressed in strongly activated neurons.
Daunorubicin then intercalates into the DNA and inhibits tran-
scription, leading to cell death through apoptosis (Momparler et
al., 1976; Bakina and Farquhar, 1999; Ghosh et al., 2000; Pfarr
et al., 2015). This results in selective lesioning of only the most
active -gal-expressing neurons (Koya et al., 2009). Daunorubi-
cin also inhibits calcium-dependent action potentials in a revers-
ible manner (Engeln et al., 2016). Studies using the Daun02
inactivation procedure demonstrated causal roles of neuronal
ensembles in different brain areas in context-induced reinstate-
ment of cocaine and heroin seeking (Bossert et al., 2011; Cruz et
al., 2014), incubation of heroin and nicotine craving (Fanous et
al., 2012; Funk et al., 2016), and alcohol seeking and taking, and
withdrawal symptoms (Pfarr et al., 2015; de Guglielmo et al.,
2016).
Materials andMethods
Subjects
We used male Sprague Dawley rats (n 74; Charles River Laboratories)
and male and female Fos-lacZ transgenic rats (n  51; 7 males and 44
females; Koya et al., 2009), weighing 175–350 g at the beginning of the
experiments. We group housed (two per cage) the rats by sex for 1–3
weeks before surgery and then individually housed them after intrave-
nous surgery. In all experiments, we brought the rats to the self-
administration chambers on the first training day and kept them in these
chambers during the self-administration, voluntary abstinence, and re-
lapse test phases. We maintained the rats on a reverse 12 h light/dark
cycle (lights off at 8:00 A.M.). The rats had free access to standard labo-
ratory chow and water throughout the entire experiment. Our procedures
followed the guidelines outlined in the National Institutes of Health Guide
for the Care and Use of Laboratory Animals (http://grants.nih.gov/grants/
olaw/Guide-for-the-Care-and-Use-of-Laboratory-Animals.pdf). We exc-
luded four SpragueDawley and eightFos-lacZ transgenic rats due to catheter
problems or poor health.
Surgery
We anesthetized the rats with isoflurane (5% induction; 2–3% mainte-
nance) and injected ketoprofen (2.5 mg/kg, s.c.; Butler Schein Animal
Health) after surgery and the following day to relieve pain and decrease
inflammation. We allowed the rats to recover from surgery for 3–4 d.
Intravenous surgery
We performed the intravenous surgeries before palatable food self-
administration training.We inserted SILASTIC catheters into the jugular
vein as described previously (Caprioli et al., 2015b) and placed the distal
end of the catheters into the jugular vein; we attached the proximal end to
a modified 22 gauge cannula to be placed on the back in the midscapular
region. We flushed the catheters daily with sterile saline containing gen-
tamicin (4.25 mg/ml; APP Pharmaceuticals) every day during the recov-
ery and training phases.
Intracranial surgery
In experiment 2, we performed the intracranial surgery at the same time
of the intravenous surgery because we tested the rats after 1 and 21
abstinence days. In experiments 3–4 (Daun02 inactivation), in which we
tested the rats only on day 21, we performed the intracranial surgery on
abstinence day 1 after the end of the methamphetamine self-admini-
stration training phase. We gave the rats 3–4 d to recover before the
voluntary abstinence phase (see below). We implanted bilateral guide
cannulae (23 gauge; Plastics One) 1 mm above the DMS. The Paxinos
andWatson (2008) coordinates (nose bar set at3.3mm) for DMSwere
as follows: distance from bregma: anteroposterior,1.2 mm; mediolat-
eral, 2.4 mm (8° angle); and dorsoventral, 4.3 mm (Bossert et al.,
2009; Li et al., 2015c). We anchored the cannulas to the skull with jewel-
er’s screws and dental cement.
Drugs
We received ()-methamphetamine-HCl (methamphetamine) from
the National Institute on Drug Abuse pharmacy.We chose a unit dose of
0.1 mg/kg for self-administration training based on our previous studies
(Caprioli et al., 2015a,b). In experiment 2 (intracranial injections), we
dissolved SCH39166 (Tocris Bioscience) and raclopride (Sigma-Aldrich)
in sterile water (2mg/ml) and injected the drugs bilaterally into the DMS
at doses of 1.0g/0.5l/side (15minpretreatment time). These doses are
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also based on a pilot study in which we found that DMS SCH39166 and
raclopride injections had no effect on operant responding for food pellets
(data not shown). In experiment 3 and 4, we dissolved Daun02 (4g/1.0
l/side; Sequoia Research Products) in vehicle solution containing 5%
DMSO, 6% Tween-80, and 89% 0.1 M PBS. We chose the Daun02 con-
centration based on our previous studies (Koya et al., 2009; Bossert et al.,
2011; Cruz et al., 2014; Warren et al., 2016). We injected Daun02 at a
higher volume than the dopamine receptor antagonists to ensure reliable
inactivation of the activated Fos-positive DMS neurons.
Intracranial injections
Three days before the intracranial injections (vehicle, SCH39166, raclo-
pride, or Daun02), we habituated rats to the injection procedure. The
habituation consisted of three phases (3 min each). We first exposed the
rats to the injection context (an empty cage containing bedding). The day
after, we gently removed the cannula blockers before exposing the rats to
the injection context. During the last day of habituation, we gently low-
ered down the injectors and placed them in the injection context. On the
test day, we connected the syringe pump (Harvard Apparatus) to 10 l
Hamilton syringes and attached the Hamilton syringes to the 30 gauge
injectors via polyethylene-50 tubing; the injectors were extended 1 mm
below the tips of the guide cannulas. In experiment 2, we injected vehicle
(saline), SCH39166, or raclopride over 1 min and left the injectors in
place for an additional 1 min to allow diffusion. In experiments 3 and 4,
we injected vehicle or Daun02 over 2 min and left the injectors in place
for 2 additional minutes to allow diffusion.
RNAscope in situ hybridization assay
We performed RNA ISH for Fos, Drd1, and Drd2 mRNAs as described
previously (Li et al., 2015c; Rubio et al., 2015; Warren et al., 2016). Sixty
minutes after the beginning of the test session, we briefly anesthetized the
rats with isoflurane (30 s) and decapitated them. We rapidly extracted
and froze their brains for 20 s in isopentane at40°C. We stored brains
at 80°C until use. We then collected dorsal striatum coronal sections
(16 m) directly onto Superfrost Plus slides (Fisher Scientific). We used
an RNAscope Multiplex Fluorescent Reagent Kit (Advanced Cell Diag-
nostics) and performed the ISH assay according to the user manual for
fresh-frozen tissue and as described previously (Li et al., 2015c; Rubio et
al., 2015; Warren et al., 2016). On the first day, we fixed brain slices in
10% neutral buffered formalin (Fisher Scientific) for 20 min at 4°C. We
rinsed the slices three times in PBS and dehydrated the slices in 50, 70,
100, and 100% ethanol.We stored slices in fresh 100% ethanol overnight
at20°C. On the second day, we first dried the slides at room tempera-
ture for 10 min. To limit the spreading of the solutions, we drew a hy-
drophobic barrier on slides around brain slices.
We then treated the slides with protease solution (pretreatment 4) at
room temperature for 20 min and then washed it off. We then applied
target probes for Fos, Drd1, and Drd2 to the slides and incubated them
at 40°C for 2 h in the HybEZ oven. Each RNAscope target probe
contains a mixture of 20 ZZ oligonucleotide probes that are bound to
the target RNA, as follows: Fos-C3 probe (GenBank accession number
NM_022197.2; target nt region, 473-1497);Drd1-C1 probe (GenBank
accession number NM_012546.2; target nt region, 104-1053); and
Drd2-C2 probe (GenBank accession number NM_012547.1; target nt
region, 445-1531). Next, we incubated the slides with preamplifier
and amplifier probes (AMP1, 40°C for 30 min; AMP2, 40°C for 15
min; AMP3, 40°C for 30 min). We then incubated the slides with
fluorescently labeled probes by selecting a specific combination of
colors associated with each channel, as follows: green (Alexa Fluor
488 nm), orange (Alexa Fluor 550 nm), and far red (Alexa Fluor 647
nm). We used AMP4 Alt4 to detect triplex Fos, Drd1, and Drd2 in far
red, green, and red channels. Finally, we incubated sections for 20 s
with DAPI.We washed the slides with one washing buffer two times in
between incubations. After air drying the slides, we coverslipped them
with a Vectashield fluorescent mounting medium (H-1400; Vector
Laboratories). We captured fluorescent images of labeled cells in
DMS and DLS using an EXi Aqua camera (QImaging) attached to an
AxioImager M.2 microscope using a 20 objective (Carl Zeiss Mi-
croscopy) and iVision software for Macintosh, version 4.0.15 (Biovi-
sion). We performed the image capture and quantification in a blind
manner (inter-rater reliability between M.V. and M.Z., r 0.95, p
0.05).
X-gal histochemistry for -gal visualization with
Fos-lacZ rats
The X-gal assay is based on our previous studies (Koya et al., 2009;
Bossert et al., 2011; Warren et al., 2016). Seventy-five minutes after the
behavioral tests, we anesthetized the rats with isoflurane and perfused
them transcardiallywith100ml of 0.1 MPBS, pH7.4, followed by400
ml of 4% paraformaldehyde in PBS. We removed the brains and post-
fixed them in 4% paraformaldehyde for 2 h before transferring them to
30% sucrose in PBS for 48 h at 4°C. We froze the brains in dry ice and
stored them at 80°C. We collected coronal brain sections (40 m) at
approximately 1.2 mm from bregma (Paxinos and Watson, 2008) in
cryoprotectant (20% glycerol and 2% DMSO in 0.1 M PBS, pH 7.4) and
stored them at 80°C until further processing (X-gal labeling). We
washed free-floating sections three times for 10 min each in PBS and
incubated them in reaction buffer (0.1 M X-gal, 100 mM sodium phos-
phate, 100 mM sodium chloride, 5 mM EGTA, 2 mMMgCl2, 0.2% Triton
X-100, 0.05MK3FeCN6, and 0.05MK4FeCN6) for 5 h at 37°Cwith gentle
shaking. We washed the sections three times for 10 min each in PBS and
mounted them onto chrom-alum/gelatin-coated slides and air dried.We
dehydrated the slides through a graded series of alcohol (30%, 60%, 90%,
95%, 100%, and 100% ethanol), cleared them with Citrasolv, and cover-
slipped the slides with Permount. We captured bright-field images of
DMS and DLS with a QImaging Exi Aqua camera attached to a Zeiss
Axioskop 2 light microscope using a 5 objective. We counted -gal-
expressing nuclei, characterized by blue nuclear staining, using iVision
software for Macintosh, version 4.0.15 (BioVision). We counted nuclei
in sampling areas around the DMS injection site (left and right hemi-
spheres) in four coronal sections per rat. We performed the image cap-
ture and quantification in a blindmanner (inter-rater reliability between
D.C. and B.L.W., r 0.98, p 0.05).
Immunofluorescence double-labeling histochemistry for Fos
plus-gal and for Fos plus NeuN
We double-labeled -gal with Fos and NeuN with Fos using fluorescent
immunohistochemistry in four Fos-lacZ rats from the vehicle groups.We
rinsed the sections three times with PBS, incubated them for 2 h in
blocking buffer containing 3% bovine serum albumin, and 5% normal
goat serum in PBS with 0.25% Triton X-100. We then incubated all
sections for at least 24 h at 4°C in anti-Fos primary antibody (1:500;
Phospho-Fos, catalog #5348S, Cell Signaling Technology; RRID:
AB_10557109) and either mouse anti--gal (1:1000; catalog #sc65670,
lot #A2611, Santa Cruz Biotechnology; RRID: AB_831022) or mouse
anti-NeuN primary antibody (1:2000 dilution of MAB377, lot
#LV1573084, Millipore; RRID: AB_2298772). Next, we rinsed the sec-
tions three times with PBS and incubated them with donkey anti-rabbit
Alexa Fluor 488 (1:500; catalog #A21206, lot #1480470, Invitrogen;
RRID: AB_141708), and goat anti-mouse Alexa Fluor 568 (1:500; catalog
#A11004; lot #1419715, Invitrogen; RRID: AB_141371) for 2 h, followed
by three rinses in PBS. We then mounted the sections on chromalum–
gelatin-coated slides and coverslipped them with Vectashield HardSet
Antifade Mounting Medium (catalog #H-1400, Vector Laboratories).
We captured fluorescent images of labeled cells using an EXi Aqua Cam-
era (QImaging) attached to an AxioImagerM.2Microscope using a 20
objective (Carl Zeiss Microscopy) and iVision software for Macintosh,
version 4.0.15 (BioVision). We quantified Fos-immunoreactive cells,
-gal-immunoreactive cells, or NeuN-immunoreactive cells, and calcu-
lated the percentage of colabeled cells from four sections using ImageJ
(four images per rat) in a blind manner.
Apparatus
We trained rats in self-administration chambers as described previously
(Caprioli et al., 2015a,b). Briefly, we equipped each chamberwith a stain-
less steel grid floor and two operant panels.We equipped the left panel of
1016 • J. Neurosci., January 25, 2017 • 37(4):1014–1027 Caprioli, Venniro et al. • Incubation of Methamphetamine Craving
the chamber with a discriminative stimulus (red light) that signaled the
insertion and subsequent availability of the methamphetamine-paired
active (retractable) lever. We equipped the right panel of the chamber
with a discriminative stimulus (white house light) that signaled the in-
sertion and subsequent availability of the food-paired active (retractable)
lever. We equipped the right wall with an inactive (stationary) lever
that had no reinforced consequences. We placed a bottle of water and
a food hopper on the side of the transparent polycarbonate door of
the chamber.
Procedures
Food pellet self-administration. Our training procedure is similar to that
described in our previous studies (Caprioli et al., 2015a,b). We trained
the rats to lever press for food during six 1 h daily sessions that were
separated by 10 min under a fixed-ratio-1 (FR1), 20 s timeout reinforce-
ment schedule, which led to the delivery of five 45 mg “preferred” or
palatable food pellets (12.7% fat, 66.7% carbohydrate, and 20.6% pro-
tein; catalog #1811155, TestDiet); pellet deliveries were paired with the
20 s discrete tone cue. Before the first one to two formal operant training
sessions, we gave the rats a 1 h magazine training sessions during which
five pellets were delivered noncontingently every 5 min. The sessions
beganwith the presentation of the white house light followed 10 s later by
the insertion of the food-paired active lever; the white house light re-
mained on for the duration of the session and served as a discriminative
stimulus for the palatable food. At the end of the session, the white light
was turned off and the active lever was retracted. We used this preferred
TestDiet pellet type in our previous studies (Cifani et al., 2012; Calu et al.,
2014; Caprioli et al., 2015a,b). To match the number of discrete cue
presentations to that of methamphetamine (see below), we limited the
number of pellet deliveries to 15/h.
Methamphetamine self-administration. Our methamphetamine self-
administration training procedure is like the one used for food. We
trained the rats to self-administer methamphetamine during six 1 h daily
sessions that were separated by 10 min under an FR1 20 s timeout rein-
forcement schedule; drug infusions were paired with the 20 s discrete
white light cue. The sessions began with the presentation of the red light
for 10 s followed by the insertion of the drug-paired active lever; the red
light remained on for the duration of the session and served as a discrim-
inative stimulus for drug availability. At the end of each 1 h session, the
red light was turned off, and the active lever was retracted. The rats
self-administered methamphetamine at a dose of 0.1 mg/kg/infusion
over 3.5 s (0.1ml/infusion). To prevent overdose, we limited the number
of infusions to 15/h.
Discrete trials choice procedure.We conducted the discrete choice ses-
sions using the same parameters (dose of methamphetamine, number of
palatable food pellets per reward, stimuli associated with the two retract-
able levers) that we used during the training phase. We allowed rats to
choose between the drug-paired and the palatable food-paired lever in a
discrete trials choice procedure.We divided each 200min choice sessions
into 20 discrete trials that were separated by 10 min as previously de-
scribed (Lenoir et al., 2007; Caprioli et al., 2015a,b; Vandaele et al., 2016).
Briefly, each trial began with the presentation of both discriminative
stimuli previously associated with palatable food or drug followed 10 s
later by the insertion of both the palatable food-paired and drug-paired
levers. Rats then had to select one of two levers. If the rats responded
within 8 min, they received the reward corresponding with the selec-
ted lever. Reward delivery was signaled by the drug-associated or food-
associated cue (white cue light or tone, respectively), the retraction of
both levers, and turning off the food andmethamphetamine discrimina-
tive cues. If the rat failed to respond on either active lever within 8 min,
both levers were retracted and their associated discriminative cues were
turned off with no reward delivery. We introduced three choice sessions
during the training phase to assess whether the choice behavior of the rats
changes over time during this phase.
Abstinence phase. After completing the training phase, we allowed the
rats to choose between the drug- and food-paired levers (delivering five
pellets) during 20 discrete choice trials for 19 sessions in experiments 1
and 2 and 14 sessions in experiments 3 and 4.
Relapse tests. The relapse tests were performed under extinction con-
ditions in the presence of drug-associated or food-associated cues con-
sisted of 60 min sessions on abstinence day 1 or abstinence day 21
(experiments 1 and 2) or 90 min sessions on abstinence day 21 (experi-
ments 3 and 4). The session began with the presentation of the red dis-
criminative cue light (experiments 1–3) or a white light (experiment 4)
followed 10 s later by the insertion of themethamphetamine-paired lever
(experiments 1–3) or the food-paired lever (experiment 4); the red or
white light remained on for the duration of the session. Active lever
presses during testing, the operationalmeasure of drug or food seeking in
incubation of drug craving studies (Pickens et al., 2011; Venniro et al.,
2016), resulted in contingent presentations of the light cue (experiments
1–3) or the tone (experiment 4) previously paired with drug or food
delivery, respectively, but not drug or food delivery.
Specific experiments
Experiment 1
Effect of methamphetamine seeking on abstinence days 1 or 21 on Fos ex-
pression in DLS and DMS. In experiment 1, we determined whether in-
cubation of methamphetamine craving is associated with increased
neuronal activity, as assessed by the activity marker Fos (Curran and
Morgan, 1995) in DLS and DMS.We also determined the cell type of the
Fos-positive neurons in the two subregions by colabeling Fos with Drd1
and Drd2 receptors. We used four groups of rats (n 3–5/group) in an
experimental design that included the between-subjects factors of test
condition (no test, relapse test) and abstinence day (days 1 and 21). The
experiment consisted of the following three phases: training phase, dis-
crete choice voluntary abstinence phase, and relapse tests.
Training. We first trained rats to self-administer palatable food pellets
(six sessions, 6 h/session; five pellets/reward delivery) and then trained
them to self-administer methamphetamine (12 sessions, 6 h/session;
0.1 mg/kg/infusion).
Discrete choice voluntary abstinence. We determined food versus
methamphetamine choice after every three consecutive drug self-
administration sessions in all groups (three choice tests) and for 19 d
(voluntary abstinence) preceding the abstinence day 21 relapse test.
Relapse tests. We tested the rats for methamphetamine seeking under
extinction conditions on abstinence days 1 and 21. Immediately after the
60 min relapse tests, we anesthetized the rats and processed their brains
for the RNAscope in situ hybridization assay. For the no-test rats, we
brought them to the perfusion room from their home cage and perfused
them on the same day and time as the relapse test rats. We matched the
rats in the different groups for methamphetamine intake during the
training phase.
Experiment 2
Effect of DMS SCH39166 or raclopride injections on incubation ofmetham-
phetamine craving. In experiment 1, we found selective time-dependent
increases in Fos expression in DMS, but not in DLS, and that Fos was
colabeledwith bothDrd1 andDrd2. Based on these results, in experiment
2 we determined the causal role of DMS dopamine receptors in the
incubation of methamphetamine craving after voluntary abstinence.We
used six groups of rats (n 9–11/group) in a fully factorial experimental
design that included the between-subjects factors of drug condition (ve-
hicle, 1.0g/side SCH39166, and 1.0g/side raclopride) and abstinence
day (days 1 and 21). The experiment consisted of the following three
phases: training phase, discrete choice voluntary abstinence phase, and
relapse tests.
Training. The experimental conditions were identical to those de-
scribed in experiment 1.
Discrete choice voluntary abstinence. The experimental conditions were
identical to those described in experiment 1. We habituated the rats to
the injection procedure for 3 d during this phase.
Relapse tests. We tested rats for methamphetamine seeking under ex-
tinction conditions on abstinence days 1 and 21. We injected either the
D1 receptor antagonist SCH39166 (1.0g/0.5l/side) or theD2 receptor
antagonist raclopride (1.0g/0.5l/side) into the DMS and determined
its effect on both nonincubatedmethamphetamine seeking in the relapse
test performed on abstinence day 1 and on incubatedmethamphetamine
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seeking on abstinence day 21. The length of the test session was 60 min.
We matched the rats in the different groups for methamphetamine in-
take during the training phase.
Finally, to verify that SCH39166 and raclopride at the dose we used in
the relapse tests does not nonselectively decrease operant responding, we
retrained 19 rats (n 6–7/group) after the day 21 testing to lever press
for the food pellets for 1 h/d. After 3 training sessions, we injected the rats
with vehicle (0.5l/side), SCH39166 (1.0g/0.5l/side), and raclopride
(1.0 g/0.5 l/side) 10 min before a test session on day 4.
Experiment 3
Effect of Daun02 inactivation of activated DMS neurons on incubation of
methamphetamine craving. In this experiment, we used the Daun02 in-
activation procedure (Koya et al., 2009; Bossert et al., 2011) to determine
whether activated neuronal ensembles in DMS play a causal role in incu-
bated methamphetamine seeking. We used two groups of female rats
(n 11–14/group) in an experimental design that included the between-
subject factor of Daun02 dose (0 and 4 g/1.0 l/side). We used female
rats because in a recent study (Venniro et al., 2017) we found no sex
differences in methamphetamine self-administration, choice-based vol-
untary abstinence, and incubation of methamphetamine craving under
conditions identical to those used in the present study. Experiment 3
consisted of the following four phases: training phase, discrete choice
test, induction day, and relapse tests.
Training. The training conditions were identical to those of experi-
ments 1 and 2.
Discrete choice. We determined food versus methamphetamine
choice after every three consecutive drug self-administration sessions
(three choice tests) and for 14 d (voluntary abstinence) preceding the
induction day. There were fewer voluntary abstinence choice sessions
in experiment 3 (and experiment 4) than in experiments 1 and 2,
because we performed the intracranial surgery on abstinence days 1
and 2 and gave the rats 3–4 d to recover before starting the choice
sessions.
Induction session. On abstinence day 18, we briefly exposed the rats to
the methamphetamine self-administration context and cues associated
with methamphetamine injections in a 15 min extinction session to in-
duce Fos in DMS. Next, 75 min after the induction session, a time of
strong Fos and -gal expression (Koya et al., 2009), we injected the rats
with Daun02 (to inhibit the Fos-positive activated neurons) or vehicle.
Between the induction day and the relapse test, we left the rats undis-
turbed in the self-administration chambers except for daily handling.
Relapse test. On test day (abstinence day 21), 3 d after the induction
day, we tested all rats for methamphetamine seeking under extinction
conditions for 90min. Immediately after the test session, we perfused the
rats and extracted their brains for a subsequent X-gal histochemistry
assay of -gal expression in DMS and DLS, and verification of cannula
placements.
Experiment 4
Effect of Daun02 inactivation of activated DMS neurons on food seeking.
Based on the results of experiment 3, we hypothesized that the Daun02
manipulation selectively inactivated the activatedDMSneurons thatme-
diate incubation of methamphetamine craving, but not neurons that
encode other non-drug-related learned associations like the learned as-
sociations between the palatable food and cues associated with this food.
To test this hypothesis, we used two groups of male and female rats (n
13/group) in an experimental design that included the between-subject
factor of Daun02 dose (0, 4 g/1.0 l/side). Experiment 4 consisted of
the following four phases: training phase, discrete choice test, induction
day, and food relapse tests.We predicted that the selective inactivation of
DMS neurons activated by methamphetamine-associated cues on the
induction day would not decrease food seeking during a relapse test
session 3 d later.
Training. The training conditions were identical to those of experi-
ments 1–3.
Discrete choice. The discrete choice conditions were identical to those
of experiment 3.
Induction day. The induction day conditions were identical to those of
experiment 3.
Relapse test. On test day (abstinence day 21), 3 d after the induction
day, we tested all rats for food seeking under extinction conditions for 90
min. The test session beganwith the presentation of the food discriminative
cue (white house light) followed10 s later by the insertionof the food-paired
active lever; during testing, lever presses on the food-paired lever led to
contingent presentations of the 20 s discrete tone cue but not the food.
Immediately after the test session, we perfused the rats and extracted their
brains for a subsequent X-gal histochemistry assay of -gal expression in
DMS and DLS, and verification of cannula placements.
Statistical analyses
Behavioral data. We analyzed the data with the statistical program SPSS
using the GLM module. For the training phase, we analyzed the data
separately for food rewards and drug infusions, using the within-subjects
factor of session. For the choice sessions, we analyzed the data with
repeated-measures ANOVA, using the within-subjects factors of reward
type (food, methamphetamine) and choice session. For the relapse tests
in experiment 1, we used one-way ANCOVA with the between-subjects
factor of abstinence day (days 1 and 21). For the relapse tests in experi-
ment 2, the statistical analysis of nonreinforced active lever presses in-
cluded the between-subjects factors of drug condition (vehicle,
SCH39166, raclopride) and abstinence day. We also used a mixed
ANOVA to analyze the 60 min time course for the test on day 21, using
the between-subjects factor of drug condition and the within-subjects
factor of session minutes (20, 40, and 60 min). For experiments 3 and 4,
we analyzed active lever-press data using one-way ANCOVA with the
between-subjects factor of Daun02 dose (0, 4g/1.0l/side). For exper-
iments 3 and 4, we also used amixed ANOVA to analyze the 90min time
course data for day 21 with the between-subjects factor of Daun02 dose
and the within-subjects factor of session minutes (30, 60, and 90 min).
For all the analyses of the behavioral data of the relapse tests, we used
inactive lever presses as a covariate.
RNAscope and immunohistochemistry data. In experiment 1, we
analyzed Fos expression with a one-way ANOVA that included the
between-subject factor group (no test, day 1 test, day 21 test). For
experiment 3, we analyzed -gal labeling with a mixed ANOVA that
included the between-subjects factor of Daun02 dose and the within-
subjects factor of dorsal striatum subregion (DMS, DLS). For exper-
iment 4, we analyzed -gal labeling with a one-way ANOVA that
included the between-subject factor of Daun02 dose (0 and 4 g/1.0
l/side). Because our multifactorial ANOVAs yielded multiple main
and interaction effects, we only report significant effects that are
critical for data interpretation. Finally, we followed up on significant
main and interaction effects (p  0.05) using Fisher’s PLSD post hoc
tests.
Results
Experiment 1
Effect of methamphetamine seeking on abstinence days 1 or 21 on
Fos expression in DLS and DMS
The time line of experiment 1 is shown in Figure 1A.
Food and methamphetamine training. The rats increased their
food andmethamphetamine intake over sessions (Fig. 1B) and, as
in our previous study, extended daily access to methamphet-
amine led to the escalation of drug intake (Krasnova et al., 2014;
Caprioli et al., 2015b). The repeated-measures ANOVA showed a
significant effect of session for both food (F(5,75) 4.9, p 0.001)
andmethamphetamine (F(11,165) 18.7, p 0.0001). During the
three discrete choice sessions, the rats showed a strong prefer-
ence for the food that increased over time (Fig. 1C). The sta-
tistical analysis showed a significant interaction between
reward type and session (F(2,30)  7.3, p  0.003).
Abstinence phase. During the 3 week abstinence period, the
rats showed a strong preference for the food, resulting in either
no or minimal (1–2 infusions/d) methamphetamine intake (Fig.
1D). The repeated-measures ANOVA showed a significant main
effect of reward type (F(1,7) 158.6, p 0.0001).
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Relapse tests. Methamphetamine seeking in the relapse tests
was higher after 21 abstinence days than after 1 d, demonstrating
incubation of methamphetamine craving after voluntary absti-
nence (Fig. 1E). The statistical analysis, which included the
between-subjects factor of abstinence day and inactive lever
presses as the covariate, showed a main effect of abstinence day
(F(1,7) 27.3, p 0.001).
Fos and Fos plus Drd1 or Drd2 RNAscope double-label data.
Fos expression in the relapse tests was higher after 21 abstinence
days than after 1 abstinence day in DMS but not in DLS (Fig.
2A,B). There were no differences in Fos levels in the no-test
groups on abstinence days 1 and 21. Thus, we combined their
data to a single no-test group (termed herein no test, n 6). The
statistical analysis, which included the between-subjects factor
group (no test, test day 1, test day 21) showed a significant main
effect of this factor for DMS (F(2,13) 7.0, p 0.009) but not for
DLS (F(2,13) 0.4, p 0.66). We found no evidence for cell-type
specificity of the activated (Fos-positive) DMS neurons on absti-
nence day 21 (48  9% and 43  8% of the Fos-positive cells
coexpressed Drd1 or Drd2, respectively; 9  2% of the Fos-
positive cells did not coexpress Drd1 or Drd2). Representative
pictures of Fos/Drd1/Drd2 triple labeling by RNAscope in situ
hybridization are shown in Figure 2, A and B.
Experiment 2
Effect of DMS SCH39166 or raclopride
injections on incubation of
methamphetamine craving
The time line of experiment 1 is shown in
Figure 3A.
Food and methamphetamine training.
The number of food and methamphet-
amine rewards earned increased over ses-
sions (Fig. 3B). The repeated-measures
ANOVA showed a significant effect of
food (F(5,285)  14.9, p  0.0001) and
methamphetamine rewards (F(11,616) 
71.2, p  0.0001). During the three dis-
crete choice sessions, the rats showed a
strong preference for the food that in-
creased over time (Fig. 3C). The statistical
analysis showed a significant interaction be-
tweenrewardtypeandsession(F(2,114)43.1,
p 0.0001).
Abstinence phase. During the 3 week
abstinence period, the rats showed a
strong preference for the food, resulting in
either no or minimal (1–2 infusions/d)
methamphetamine intake (Fig. 3D). The
repeated-measures ANOVA showed a sig-
nificant main effect of reward type
(F(18,522) 2.1, p 0.004).
Relapse tests. DMS injections of
SCH39166 and raclopride decreased
methamphetamine seeking in the relapse
tests on abstinence day 21 but not day 1
(Fig. 3E). The statistical analysis, which
included the between-subjects factors of
drug condition and abstinence day, and
inactive lever-presses as a covariate,
showed a significant interaction between
abstinence day and drug condition (F(2,51)
 3.5, p  0.036). We also analyzed the
time course of extinction responding on
day 21 using the between-subjects factor of drug condition and
the within-subjects factor of session minutes (20, 40, and 60
min). This analysis showed significant effects of significant inter-
action between drug condition and session time (F(4,110)  3.9,
p 0.006; Fig. 3F). Inactive lever presses in the relapse tests were
very low (mean SEM of 1.7 0.3 and 0.7 0.1/60min for day
1 and day 21 tests across the different experimental conditions;
data not shown).
Finally, SCH39166 or raclopride at the dose we used in the
relapse tests had no effect on operant responding for the food
pellets (mean  SEM number of active lever presses per 1 h of
44 7, 51 5, and 52 9, respectively, for vehicle, SCH39166
(1 g/side), and raclopride (1 g/side).
Experiment 3
Effect of Daun02 inactivation of activated DMS neurons on
incubation of methamphetamine craving
The time line of experiment 1 is shown in Figure 4A.
Food and methamphetamine training. The rats increased their
food and methamphetamine intake over sessions (Fig. 4B). The
repeated-measures ANOVA showed a significant effect of session
for both food (F(5,120)  22.6, p  0.0001) and methamphet-
amine (F(11,264)  15.2, p  0.0001). During the three discrete
Figure 1. Incubation ofmethamphetamine (Meth) craving is associatedwith the activation of DMS, but not of DLS (behavioral
data).A, Timeline of the experiment.B, Food andmethamphetamine self-administration (mean SEMnumber of food rewards;
5pellets/lever press) andmethamphetamine infusionsduring the6h sessions.C, Discrete choice sessionsduring training:mean
SEM food rewards andmethamphetamine infusions earned during the three discrete choice sessions during training.D, Voluntary
abstinence:mean SEMnumber of food rewards andmethamphetamine infusions earnedduring the19discrete choice sessions.
E, Relapse tests:mean SEMnumber of nonreinforced lever presses during the60min test sessions. *p0.05different fromday
1. n 5/group. Circles represent individual data. SA, self-administration.
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choice sessions, the rats showed a strong preference for the food
(Fig. 4C). The statistical analysis showed a significant main effect
of reward type (F(1,24) 136.5, p 0.0001).
Abstinence phase. During the 3 week abstinence period, the
rats showed a strong preference for the food, resulting in either
no or minimal (1–2 infusions/d) methamphetamine intake (Fig.
4D). The repeated-measures ANOVA showed a significant main
effect of reward type (F(1,24) 659.0, p 0.0001).
Induction day. On induction day, active lever pressing in the
15 min extinction session was not different between the groups
that received vehicle or Daun02 injections 90 min after the onset
of the session (mean  SEM: vehicle, 28.2  7.4 level presses;
Daun02, 20.6 3.7 level presses; F(1,23) 1.0, p 0.34).
Relapse tests. Daun02 inactivation of DMS neurons activated
during a short 15 minmethamphetamine extinction session (absti-
nence day 18) decreasedmethamphetamine seeking 3 d later (absti-
nence day 21; Fig. 4E). The statistical analysis of active lever presses,
which included the between-subject factor of Daun02 dose and in-
active lever presses as a covariate, showed a main effect of Daun02
dose (F(1,22) 10.0, p 0.005).We also analyzed the time course of
active lever pressing during the test session using the between-
subject factor of Daun02 dose and the within-subjects factor of ses-
sionminutes. This analysis showed a significant interaction between
Daun02dose and sessionminutes (F(2,46)13.2,p0.0001). These
resultsindicatethatDaun02decreasedtheresponsetothemethamphet-
amine cues during early but not late testing (Fig. 4F).
Figure 2. Incubation of methamphetamine craving is associated with the activation of DMS, but not of DLS: RNAscope data. A, Fos expression in Drd1- and Drd2-positive cells: DMS.
Left, Fos-positive cells in the DMS in rats that were tested for relapse to methamphetamine seeking on abstinence days 1 and 21 (*p 0.05, different from day 1). Black dotted line
indicates Fos expression level in the no-test control group. Circles represent individual data. Right, Percentages of Fos-positive cells that coexpress Drd1mRNA (Drd1 plus Fos), Drd2mRNA
(Drd2 plus fos), or neither (Fos alone) in DMS. Bottom panels, Representative images of DMS region (left) and Fos labeling in the no test and relapse test groups (middle), and Drd1 or Drd2
labeling in the relapse test group (right; Fos, white; Drd1, green; Drd2, red; DAPI, blue). Arrows indicate representative cells. B, Fos expression in Drd1- and Drd2-positive cells. Left, DLS
Fos-positive cells in the DLS in rats that were not tested or tested for methamphetamine seeking in an relapse test on abstinence days 1 and 21. Black dotted line indicates Fos expression
level in the No-test controls. Circles represent individual data. Right, Percentages of Fos-positive cells that coexpress Drd1 (Drd1 plus Fos), Drd2 mRNA (Drd2 plus Fos), or neither (Fos
alone) in DLS. Bottom panels, Representative images of DLS region (left; scale bar, 1000m) and Fos labeling in both the no-test and relapse test groups (middle; scale bar, 20m), and
Drd1 or Drd2 labeling in the relapse test group (right; scale bar, 20 m; Fos, white; Drd1, green; Drd2, red; DAPI, blue). Arrows indicate representative cells.
n 5/group for day 1 and day 21 test groups, and n 6 for the no-test group (black dashed line).
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X-gal histochemistry. Daun02 injections decreased the number
of -gal-labeled neurons in DMS but not in DLS, which con-
firmed the successful of inactivation of induction day-activated
DMS neurons (Fig. 4H). The statistical analysis that included the
between-subjects factors of Daun02 dose and the within-subject
factor of dorsal striatum subregion showed a significant interac-
tion between the two factors (F(1,23)  103.6, p  0.0001). Rep-
resentative pictures of -gal staining are shown in Figure 4I.
We also determined Fos plus-gal double-labeling inDMS to
verify that our Daun02 manipulation targets the Fos-expressing
neurons activated during the relapse tests. We found that 79.4
1.1% of the Fos-positive cells coexpressed -gal (Fig. 4J). This
percentage of coexpression is similar to those we observed in our
previous studies (Bossert et al., 2011; Fanous et al., 2012; Funk et
al., 2016), and the100% coexpression likely reflects differences
in the sensitivity of our assay conditions for detecting Fos versus
-gal. Finally, we determined Fos plus NeuN double-labeling in
DMS to determine the approximate proportion of the strongly
activated neurons during the late abstinence relapse test. We
found that 4.6  0.36% of the NeuN-positive cells coexpressed
Fos (Fig. 4K). This percentage of Fos plus NeuN coexpression,
reflecting the percentage of neurons strongly activated during the
relapse test, is similar to the percentage of Fos plus NeuN coex-
pression we observed in our previous studies using the Daun02
procedure to study mechanisms of relapse to drug seeking
(Bossert et al., 2011; Fanous et al., 2012; Cruz et al., 2014; Funk et
al., 2016).
Experiment 4
Effect of Daun02 inactivation of activated DMS neurons on
food seeking
The time line of experiment 1 is shown in Figure 5A.
Food and methamphetamine training. The rats increased their
food and methamphetamine intake over sessions (Fig. 5B). The
repeated-measures ANOVA showed a significant effect of session
for both food (F(5,125) 5.4, p 0.0001) andmethamphetamine
(F(11,275) 48.5, p 0.0001). During the three discrete choice
sessions, the rats showed a strong preference for the food (Fig.
5C). The statistical analysis showed a significant interaction
between reward type and session (F(2,54)  8.7, p  0.0001).
Abstinence phase. During the 3 week abstinence period, the
rats showed a strong preference for the food, resulting in either
no or minimal (1–2 infusions/d) methamphetamine intake (Fig.
Figure 3. Blockade of DMS D1 and D2 family receptors decreased incubated methamphetamine seeking after voluntary abstinence. A, Timeline of the experiment. B, Food and
methamphetamine (Meth) self-administration (SA): mean SEM number of food rewards and methamphetamine infusions during the 6 h sessions. C, Discrete choice sessions during
training: mean SEM number of food rewards and methamphetamine infusions earned during the three discrete choice sessions during training. D, Voluntary abstinence: mean SEM
number of food rewards and methamphetamine infusions earned during the 19 discrete choice sessions. E, Relapse tests: mean SEM number of nonreinforced lever presses during the
60 min relapse tests on abstinence days 1 and 21. *Different from day 1, p 0.05. F, Lever presses on the previously active lever during the 60 min relapse session on day 21. Circles
represent individual data. *Different from vehicle, p 0.05. G, Representative photomicrograph of the cannula placement in DMS (scale bar, 800m). n 9 for day 1 groups and n
10 –11 for day 21 groups.
Caprioli, Venniro et al. • Incubation of Methamphetamine Craving J. Neurosci., January 25, 2017 • 37(4):1014–1027 • 1021
Figure 4. Selective inhibition of methamphetamine (Meth) incubation-related activated DMS neurons with Daun02 decreased incubation of drug craving. A, Timeline of the
experiment. B, Food and methamphetamine self-administration (SA): mean SEM number of food rewards and methamphetamine infusions during the 6 h sessions. C, Discrete choice
sessions during training: mean  SEM number of food rewards and methamphetamine infusions earned during the three discrete choice sessions during training. D, Voluntary
abstinence: mean  SEM number of food rewards and methamphetamine infusions earned during the 14 discrete choice sessions. E, Relapse tests: mean  SEM number of
nonreinforced presses on the methamphetamine-associated active lever during the 90 min relapse tests on abstinence day 21. Circles represent individual data. F, Time course of the
methamphetamine-associated active lever presses during testing. G, Representative photomicrograph of cannula placements in DMS (scale bar, 800m). H,-Gal-positive cells in the
DMS (top) and DLS (bottom) in rats that were tested for relapse to methamphetamine seeking on abstinence day 21. Circles represent individual data. I, Representative photomicro-
graph of -gal staining (top, DMS; bottom, DLS). *Different from vehicle, p 0.05. n 11–14/group. J, K, Fos plus -gal and NeuN plus Fos double labeling: representative photo-
micrographs (20) of Fos plus -gal (J ) or NeuN plus Fos (K ) in DMS of vehicle-treated Fos-LacZ rats (n  4) that were tested for relapse to methamphetamine seeking on
abstinence 21. SA, self-administration.
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5D). The repeated-measures ANOVA showed a significant main
effect of reward type (F(1,25) 5507.4, p 0.0001).
Induction day. On induction day, active lever pressing in the
15 min methamphetamine extinction session was not different
between the groups that received vehicle or Daun02 injections 90
min after the onset of the session (mean SEM: vehicle, 19.6
4.6 lever presses; Daun02, 17.2 2.5 lever presses; F(1,24) 0.2,
p 0.65).
Relapse tests. Daun02 inactivation of DMS neurons activated
during a short 15 minmethamphetamine extinction session (ab-
stinence day 18) had no effect on food seeking 3 d later (Fig. 5E).
The statistical analysis of active lever presses during the food
relapse session, which included the between-subject factor of
Daun02 dose and inactive lever presses as a covariate, showed no
effect of Daun02 dose (F(1,23) 0.0, p 0.98). The analysis of the
time course of active lever presses during the food relapse session
Figure 5. Selective inhibition of methamphetamine (Meth) relapse-encoding DMS neuronal ensembles with Daun02 had no effect on food seeking. A, Timeline of the experiment. B, Food and
methamphetamine self-administration (SA): mean SEM number of food rewards andmethamphetamine infusions during the 6 h sessions. C, Discrete choice sessions during training: mean
SEMnumber of food rewards andmethamphetamine infusions earned during the three discrete choice sessions during training.D, Voluntary abstinence:mean SEMnumber of food rewards and
methamphetamine infusions earned during the 14 discrete choice sessions. E, Food relapse tests: mean SEM number of nonreinforced presses on the food-associated active lever during the 90
min test session on abstinence day 21. Circles represent individual data. F, Time course of the food-associated active lever presses.G, Representative photomicrograph of cannula placements in DMS
(scale bar, 800m). H,-Gal-positive cells in the DMS in rats that were tested for food seeking on abstinence 21. Circles represent individual data. I, Representative photomicrograph of-gal
staining. n 13/group. SA, self-administration.
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showed a significant effect of session time (F(2,48)  86.2, p 
0.0001) but no effect of Daun02 dose (F(2,48) 0.0, p 0.91), or
an interaction between the two factors (F(2,48)  1.0, p  0.39;
Fig. 5F).
X-gal histochemistry. Daun02 injections on induction day had
no effect on the number of -gal-labeled neurons in DMS after
the 90min food relapse session (Fig. 5H; F(1,24) 0.2, p 0.65 for
Daun02 effect). Representative pictures of -gal staining are
shown in Figure 5I.
Discussion
We report three main findings. First, incubated methamphet-
amine seeking on abstinence day 21was associatedwith increased
Fos expression in DMS but not DLS; additionally, Fos was coex-
pressed with both Drd1- and Drd2-expressing neurons. Second,
the blockade of DMS D1 family and D2 family receptors selec-
tively decreased incubated methamphetamine craving after
prolonged voluntary abstinence. Most important, Daun02 inac-
tivation of DMS neurons activated during a short relapse session
on induction day (abstinence day 18) decreased incubatedmeth-
amphetamine seeking andDMSneuronal activity 3 d later during
the relapse test on abstinence day 21. In contrast, the same
Daun02 inactivation procedure had no effect on food seeking,
suggesting that striatal neuronal ensembles controlling incu-
bated methamphetamine seeking do not play a role in food
seeking. Together, our results suggest that dopamine transmis-
sion through Drd1 and Drd2 in activated DMS neuronal ensem-
bles is critical to the incubation of methamphetamine craving
after voluntary abstinence. Finally, as in our previous reports
(Caprioli et al., 2015a,b) and the studies of Cantin et al., (2010)
andAhmed et al. (2013), we found that rats will voluntary abstain
from extended access psychostimulant self-administration when
given a choice between the drug and palatable food.
Methodological considerations
Several issues should be considered in the interpretation of the
present data. Onemethodological issue could be that the effect of
DMS injections of SCH39166, raclopride, or Daun02 on incu-
bated methamphetamine craving are due to nonspecific perfor-
mance deficits. This is unlikely for SCH39166 and raclopride,
because we used a dose that had no effect on operant responding
for the palatable food (see Results). As for Daun02 inactivation,
this experimental manipulation had a selective effect on meth-
amphetamine but not food seeking during the relapse tests, rul-
ing out a nonselective effect of Daun02 injections.
Another methodological issue could be that in our Daun02
inactivation procedure experiments we primarily used Fos-LacZ
female rats, while in the other experiments we usedmale Sprague
Dawley rats. In this regard, several studies demonstrated sex
differences in psychostimulant self-administration and relapse
(Carroll et al., 2004; Becker and Koob, 2016; Carroll and Lynch,
2016), including the incubation of cocaine craving after forced
abstinence (Kerstetter et al., 2008), and cue-induced reinstate-
ment of methamphetamine seeking (Cox et al., 2013). However,
it is unlikely that the use of females in the Daun02 experiment
confound data interpretation. Specifically, in experiment 4, in
which we used both male and females, we found no evidence for
sex differences inmethamphetamine self-administration (n 19
female, n  7 male; F(1,24)  0.09, p  0.8) or in the strong
preference for the palatable food over methamphetamine during
the voluntary abstinence phase (F(1,24)  1.7, p  0.21). Addi-
tionally, in a study using identical experimental conditions, we
found no evidence for sex differences in Sprague Dawley rats for
methamphetamine self-administration, preference for the palat-
able food, or the magnitude of incubated methamphetamine
seeking after either forced or voluntary abstinence (Venniro et al.,
2017).
Finally, from a brain mechanism perspective, a question for
future research is the role of DLS dopamine in the incubation of
methamphetamine craving after voluntary abstinence. The pri-
mary goal of our study was to investigate the neuronal phenotype
and the causal role of dorsal striatum Fos-positive neuronal en-
sembles in the incubation of methamphetamine craving after
voluntary abstinence. Therefore, we did not investigate the causal
role of DLS in incubated methamphetamine seeking, because we
did not observe time-dependent increases in Fos expression after
the relapse tests on abstinence days 1 and 21. However, these
correlational data do not rule out a role of DLS in the incubation
of methamphetamine craving after voluntary abstinence. In this
regard, based on previous studies on the role of DLS dopamine in
incubation of methamphetamine after forced abstinence (Li et
al., 2015c), cocaine seeking under a second-order reinforcement
schedule (Vanderschuren et al., 2005; Belin and Everitt, 2008),
and context-induced reinstatement of heroin seeking (Bossert et
al., 2009), it is likely that DLS injections of dopamine receptor
antagonists will also decrease incubatedmethamphetamine seek-
ing after voluntary abstinence.
Role of dorsomedial striatum dopamine and neuronal
ensembles in incubation of methamphetamine craving
In two studies published over a decade ago, Ito et al. (2000, 2002)
reported that cocaine-seeking behavior under a second-order re-
inforcement schedule causes a selective increase in dopamine
release in the lateral part of the dorsal striatum but not in accum-
bens core or shell. These seminal studies have led to a series of
functional studies in several laboratories that have established a
critical role of DLS dopamine transmission and neuronal activity
in drug seeking controlled by drug-associated cues and relapse/
reinstatement of drug seeking (Fuchs et al., 2006; Everitt et al.,
2008; Belin et al., 2009; Pacchioni et al., 2011; Corbit et al., 2012;
Lesscher and Vanderschuren, 2012; Bossert et al., 2013). At pres-
ent, however, much less is known about the role of DMS dopa-
mine and neuronal activity in drug seeking and relapse.
In the present study we used classical pharmacological meth-
ods and the newer Daun02 inactivation procedure (Koya et al.,
2009) to demonstrate a critical role of DMS D1 and D2 family
receptors and Fos-expressing neuronal ensembles in relapse to
methamphetamine seeking after prolonged voluntary absti-
nence. These data extend our recent findings showing that the
DMS is activated during tests for the incubation of methamphet-
amine craving after prolonged forced abstinence (30 d) and that
DMS injections of the D1 family receptor antagonist SCH23390
decreases the incubated drug-seeking response (Li et al., 2015c).
Unlike this previous study, however, in the present study we did
not observe increases in DLS activity (assessed by RNAscope of
Fos) during the relapse/incubation tests. These different results
for DLS activity suggest that the mechanisms underlying the in-
cubation ofmethamphetamine craving after forced versus volun-
tary abstinence can be partly dissociable.
The data fromour two incubation ofmethamphetamine crav-
ing studies on the role of DMS in relapse to drug seeking extend
results from two studies demonstrating a role of DMS in alcohol
seeking (Corbit and Janak, 2016; Ron and Barak, 2016). In one
study, Wang et al. (2010) showed that the inhibition of NR2B-
containingNMDAreceptors or Src family protein tyrosine kinase
in DMS decreases alcohol priming-induced reinstatement of al-
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cohol seeking. In another study, Corbit et al. (2012) showed that
muscimol–baclofen inactivation of the DMS decreases alcohol
seeking in an extinction test after short-term but not long-term
alcohol self-administration training.
A main finding in our study was that the incubation-associated
Fos-positive DMS neurons coexpressed both Drd1 and Drd2, indi-
cating that the neuronal ensemble encoding the incubatedmetham-
phetamine seeking that we inhibited with the Daun02 procedure is
not cell type specific. The present results are consistent with our
previous results showing that after forced abstinence frommetham-
phetamine, the incubation-sensitive Fos-positive neurons in both
DMS and DLS coexpressed both Drd1 and Drd2 (Li et al., 2015c).
The current observation that the putativeDMSneuronal ensembles
thatmediate the incubation ofmethamphetamine craving is not cell
type specific is consistent with those from our previous Daun02
inactivation studies showing the that the Fos-expressing neuronal
ensembles in the nucleus accumbens (Cruz et al., 2014), ventral
mPFC (Bossert et al., 2011; Warren et al., 2016), and orbitofrontal
cortex (Fanous et al., 2012) are not cell type specific.
As can be seen in Figure 2, a small proportion of dorsal stria-
tum Fos-positive neurons did not coexpress Drd1 or Drd2. We
speculate that these activated neurons are cholinergic interneu-
rons that comprise of2%of dorsal striatumneurons (Graybiel,
1995). There is evidence that cholinergic interneurons are in-
volved in associative learning and reward processing (Pisani et al.,
2007), are strongly excited during movement (Benhamou et al.,
2014), and their activity correlates with the phasic activity of
substantia nigra pars compacta dopamine neurons (Morris et al.,
2004). A question for future research is whether the Fos-positive
neurons inDMS that do not coexpress dopamine receptors play a
role in the incubation of methamphetamine craving.
Finally, our Daun02 inactivation results showing that the se-
lective inactivation of a small proportion of activated DMS neu-
rons mimics the behavioral effects of acute dopamine receptor
blockade that interferes with the normal function of a much
larger neuronal population provide additional support for the
unique utility of this experimental procedure for studying causal
roles of neuronal ensembles in learned behaviors in rats (Cruz et
al., 2013).
Concluding remarks
We recently developed a choice-based ratmodel of drug relapse and
craving after voluntary abstinence (Caprioli et al., 2015b) and pro-
posed that our model mimics features of human relapse after the
cessation of voucher-based contingency management (Higgins et
al., 1991; Roll, 2007; Silverman et al., 2012). Here, we used RNAs-
copeandpharmacological andchemogeneticmethods to investigate
brain mechanisms of the incubation of methamphetamine craving
after voluntary abstinence. Our results show that this incubation is
associated with time-dependent increases in DMS activity and that
local D1 andD2 family dopamine receptors play a critical role in the
incubation of methamphetamine craving. Our results also indicate
thata small subsetofDMSneurons formneuronal ensembles,which
encode the learned associations betweenmethamphetamine reward
and cues and contexts associated with methamphetamine self-
administration,mediate the incubation ofmethamphetamine crav-
ing after voluntary abstinence.
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